OLVEREMBATINIB

Clinical trials for OLVEREMBATINIB explained in plain language.

Never miss a new study

Get alerted when new OLVEREMBATINIB trials appear

Sign up with your email to follow new studies for OLVEREMBATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Scientists test drug safety in people with liver damage

Knowledge-focused Recruiting now

This study aims to understand how liver problems affect how the body processes the cancer drug olverembatinib. Researchers will compare 48 people with varying degrees of liver impairment to healthy volunteers after a single dose. The goal is to gather data to help doctors safely …

Matched conditions: OLVEREMBATINIB

Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Knowledge-focused

Last updated Mar 12, 2026 13:52 UTC

OLVEREMBATINIB

Get alerted when new OLVEREMBATINIB trials appear

Scientists test drug safety in people with liver damage